Видео ютуба по тегу Speaker: Alexander Lesokhin

Lenalidomide and azacitidine with radiotherapy for patients with plasmacytomas
Lenalidomide and azacitidine with radiotherapy for patients with plasmacytomas
Multiple Myeloma Immunotherapy: Where Are We Now, with Alexander Lesokhin
Multiple Myeloma Immunotherapy: Where Are We Now, with Alexander Lesokhin
Evaluating the safety and efficacy of elranatamab in multiple myeloma
Evaluating the safety and efficacy of elranatamab in multiple myeloma
Alexander Lesokhin, MD talks about newly diagnosed multiple myeloma patients
Alexander Lesokhin, MD talks about newly diagnosed multiple myeloma patients
Initial Safety Results for Phase 2 MagnetisMM-3 Trial Presented at ASCO 2022
Initial Safety Results for Phase 2 MagnetisMM-3 Trial Presented at ASCO 2022
Alexander Lesokhin, MD explains therapy combinations for newly diagnosed multiple myeloma patients
Alexander Lesokhin, MD explains therapy combinations for newly diagnosed multiple myeloma patients
Alexander Lesokhin, MD provides an update on the CASTOR trial presented at ASCO 2016
Alexander Lesokhin, MD provides an update on the CASTOR trial presented at ASCO 2016
Dr. Lesokhin on the Current Treatment Landscape of Myeloma
Dr. Lesokhin on the Current Treatment Landscape of Myeloma
Enduring responses following cevostamab therapy in R/R multiple myeloma
Enduring responses following cevostamab therapy in R/R multiple myeloma
Alexander Lesokhin, MD discusses the development of immunotherapies for multiple myeloma patients
Alexander Lesokhin, MD discusses the development of immunotherapies for multiple myeloma patients
Can diet impact treatment outcomes and progression of patients with multiple myeloma?
Can diet impact treatment outcomes and progression of patients with multiple myeloma?
Evaluating the safety of maintenance therapy cessation in MRD negative myeloma patients
Evaluating the safety of maintenance therapy cessation in MRD negative myeloma patients
Overview of BCMA & Other Targets in Myeloma - Alexander Lesokhin, MD | MCRT Webcast Apr 10, 2021
Overview of BCMA & Other Targets in Myeloma - Alexander Lesokhin, MD | MCRT Webcast Apr 10, 2021
Novel targets in multiple myeloma
Novel targets in multiple myeloma
MagnetisMM-3: elranatamab for myeloma
MagnetisMM-3: elranatamab for myeloma
Dr. Lesokhin Discusses Exciting Advances in Multiple Myeloma
Dr. Lesokhin Discusses Exciting Advances in Multiple Myeloma
Talking to Your Oncologist about Cancer Immunotherapy
Talking to Your Oncologist about Cancer Immunotherapy